Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
19.32
+0.60 (3.21%)
At close: Oct 28, 2026

SHE:001367 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
555.83532.26471.51397.45422.78388.98
Revenue Growth
8.92%12.88%18.63%-5.99%8.69%36.58%
Gross Profit
258241.02189.6160.05156.26152.87
Operating Income
159.48142.61116.72100.9105.02105.02
Net Income
148.83135.88122.56104.67107.5994
Earnings Per Share
0.970.890.820.760.960.84
EPS Growth
18.26%8.54%7.40%-20.74%14.68%49.60%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
China
242.03234.5185.4228.33199.72
Overseas
290.23237.01212.06194.45187.07
Total
532.26471.51397.45422.78388.98

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
1,1381,0611,034943.75247.19206
Total Debt
7.427.438.120.170.781.53
Net Cash (Debt)
1,1301,0541,026943.59246.41204.47
Net Cash Growth
13.00%2.67%8.77%282.94%20.51%46.15%
Net Cash Per Share
7.366.906.876.882.211.83

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
212.77177.45167.1680.6274.95107.04
Capital Expenditures
-55.2-152.26-64.75-57.44-20.19-33.32
Free Cash Flow
157.5725.19102.4123.1754.7673.72
Free Cash Flow Growth
5829.33%-75.40%341.91%-57.68%-25.73%32.89%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
46.42%45.28%40.21%40.27%36.96%39.30%
Operating Margin
28.69%26.79%24.75%25.39%24.84%27.00%
Pretax Margin
30.67%29.45%30.07%30.36%29.28%27.90%
Profit Margin
26.78%25.53%25.99%26.33%25.45%24.16%
FCF Margin
28.35%4.73%21.72%5.83%12.95%18.95%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingOct '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.1160.1160.1700.228
Dividend Per Share Growth
-31.76%-31.77%-25.50%-
Dividend Yield
0.60%0.52%0.91%1.14%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
19.9324.2922.8228.56--
P/FCF Ratio
18.43131.0027.31128.99--
PS Ratio
5.236.205.937.52--